Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionThrive Wealth Management, LLC
Latest Disclosed Ownership3,246 shares
Latest Disclosed Value $ 1,141,954
Thrive Wealth Management, LLC reports 1.10% decrease in ownership of AMGN / Amgen Inc.

On April 9, 2026 - Thrive Wealth Management, LLC filed a 13F-HR form disclosing ownership of 3,246 shares of Amgen Inc. (MX:AMGN) valued at $1,141,954 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 3,282 shares of Amgen Inc.. This represents a change in shares of -1.10% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F AMGEN COM 031162100 3,246 -36 -1.10 1,142 6.24 0.1702
2026-01-12 2025-12-31 13F AMGEN COM 031162100 3,282 28 0.86 1,074 16.99 0.1578
2025-10-07 2025-09-30 13F AMGEN COM 031162100 3,254 -18 -0.55 918 0.55 0.1385
2025-07-09 2025-06-30 13F AMGEN COM 031162100 3,272 420 14.73 914 2.82 0.1475
2025-04-10 2025-03-31 13F AMGEN COM 031162100 2,852 -36 -1.25 889 18.09 0.1698
2025-01-16 2024-12-31 13F AMGEN COM 031162100 2,888 13 0.45 753 -18.79 0.1353
2024-10-04 2024-09-30 13F AMGEN COM 031162100 2,875 21 0.74 926 3.93 0.1700
2024-07-12 2024-06-30 13F AMGEN COM 031162100 2,854 82 2.96 892 13.07 0.1746
2024-04-16 2024-03-31 13F AMGEN COM 031162100 2,772 436 18.66 788 17.26 0.1629
2024-01-10 2023-12-31 13F AMGEN COM 031162100 2,336 1 0.04 673 7.18 0.1498
2023-10-13 2023-09-30 13F AMGEN COM 031162100 2,335 187 8.71 628 31.72 0.1670
2023-07-12 2023-06-30 13F AMGEN COM 031162100 2,148 -123 -5.42 477 -13.30 0.1235
2023-04-07 2023-03-31 13F AMGEN COM 031162100 2,271 577 34.06 549 23.65 0.1407
2023-01-25 2022-12-31 13F AMGEN COM 031162100 1,694 265 18.54 445 37.89 0.1274
2022-10-24 2022-09-30 13F AMGEN COM 031162100 1,429 213 17.52 322 8.78 0.1128
2022-07-11 2022-06-30 13F AMGEN COM 031162100 1,216 1,216 296 0.1032
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.